tirzepatide + niacinamide / Introducing Tirzepatide at the lowest
Description
In addition to baseline characteristics, semaglutide utilization was measured during follow-up, including the highest dose reached, the proportion of days patients were on their highest dose, adherence, and persistence
Why is this approval so important
If your vial is 2.5 mg/mL, 0.25 mg is usually 10 units
Source: Ryan DH, Lingvay I, Deanfield J, et al
Ecnoglutide A long-acting GLP-1 receptor agonist designed for twice-monthly or potentially monthly dosing
